IL13RA2 and central nervous system cancer: One study utilized the IL13RA2 epitope for a glioma vaccine14, and a phase I clinical trial featuring IL13RA2 targeting CAR T-cells in IL13RA2-positive glioblastoma in adults has been recently completed15.